First - line, non - cryopreserved autologous stem cell transplant for poor - risk germ - cell tumors: Experience in a developing country

Leon-Rodriguez, Eucario; Rivera-Franco, Monica M; Lacayo-Leñero, Dennis; Campos-Castro, Andrea; Meneses-Medina, Monica I.
Int. braz. j. urol ; 45(1): 74-82, Jan.-Feb. 2019. tab, graf
Artículo en Inglés | LILACS | ID: biblio-989965

Documentos relacionados

  1. First - line, non - cryopreserved autologous stem cell transplant for poor - risk germ - cell tumors: Experience in a developing country.
  2. High-dose chemotherapy with autologous stem cell support in patients with metastatic non-seminomatous testicular cancer - a report from the Swedish Norwegian Testicular Cancer Group (SWENOTECA).
  3. Current management of stage I testicular germ cell tumors in a French cancer institute. A practice analysis over the 10 past years.
  4. Managing seminomatous and nonseminomatous germ cell tumors.
  5. French AFU Cancer Committee Guidelines - Update 2022-2024: testicular germ cell cancer.
  6. Safety and efficacy of resistance training in germ cell cancer patients undergoing chemotherapy: a randomized controlled trial.
  7. Mediastinal Presentation of Testicular Embryonal Carcinoma.
  8. Long-Term Survival of Good-Risk Germ Cell Tumor Patients After Postchemotherapy Retroperitoneal Lymph Node Dissection: A Comparison of BEP × 3 vs. EP × 4 and Treating Institution.
  9. [What does the oncologist need from the pathologist in testicular cancer?]
  10. Anti-Ma2 paraneoplastic encephalitis associated with testicular germ cell tumor treated by carboplatin, etoposide and bleomycin.